cms_GA: 6790

In collaboration with The Seattle Times, Big Local News is providing full-text nursing home deficiencies from Centers for Medicare & Medicaid Services (CMS). These files contain the full narrative details of each nursing home deficiency cited regulators. The files include deficiencies from Standard Surveys (routine inspections) and from Complaint Surveys. Complete data begins January 2011 (although some earlier inspections do show up). Individual states are provides as CSV files. A very large (4.5GB) national file is also provided as a zipped archive. New data will be updated on a monthly basis. For additional documentation, please see the README.

Data source: Big Local News · About: big-local-datasette

This data as json, copyable

rowid facility_name facility_id address city state zip inspection_date deficiency_tag scope_severity complaint standard eventid inspection_text filedate
6790 MAGNOLIA MANOR OF ST SIMONS REHAB & NURSING CENTER 115582 2255 FREDERICA ROAD SAINT SIMONS ISLAND GA 31522 2013-02-14 329 D 0 1 NIB111 **NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observation, staff interview, and record review, it was determined that the facility failed to follow the physician's orders for psychoactive medications for one resident (#52) in a total sample of 38 residents. Findings include: Resident #52 was admitted in June of 2011 with [DIAGNOSES REDACTED]. There was a 1/29/13 physician's telephone order for nursing staff to discontinue giving [MEDICATION NAME] to the resident and give 0.5 milligrams (mg) of [MEDICATION NAME] twice a day. That order was on the Physician's Order Form for February, 2013 for agitation and was scheduled to be given at 9 a.m. and 5 p.m However, a review of the January and February Medication Administration Records (MARs) revealed that nursing staff failed to discontinue the [MEDICATION NAME] as ordered on [DATE]. Licensed nursing staff had given the resident both the [MEDICATION NAME] and the Risperdone, until after surveyor inquiry on 2/13/13. During a telephone interview on 2/13/13 at 3:15 p.m., Hospice Nurse HH said that she had been monitoring resident #52 for his/her response to the change in psychoactive medication from [MEDICATION NAME] to [MEDICATION NAME]. The Hospice nurse said that he/she had observed that resident #52 was more sedated and quiet since the [MEDICATION NAME] was started but, did not realize that the facility failed to stop the [MEDICATION NAME]. The Hospice nurse said that the failure to discontinue the Haloperidal could contribute to sedation for resident #52. In an interview on 2/14/13 at 8:30 a.m., the Director of Nurses (DON) stated that, after surveyor inquiry, the Medical director had made rounds last evening (2/13/13) and evaluated resident #52. Review of the 2/13/13 Physician's Progress Note revealed that the physician had documented that there were no adverse effects from the [MEDICATION NAME] and [MEDICATION NAME] both having been given to resident #52 and that the [MEDICATION NAME] was discontinued yesterday (2/13/13). 2017-10-01